Nutrisystem announces sponsorship of American Diabetes Association’s annual Step Out: Walk to Stop Diabetes
FORT WASHINGTON, Pa. — Nutrisystem on Monday announced it will sponsor and have more than 100 employees and their families, including CEO Dawn Zier and new Nutrisystem ambassador, Andy Baldwin, join the company at the American Diabetes Association’s annual Step Out: Walk to Stop Diabetes in Philadelphia. On Oct. 5, Baldwin will walk with Zier and Fort Washington-based Nutrisystem employees as part of the company’s ongoing commitment to support the fight against diabetes.
Baldwin, a family physician, is perhaps best known for his stint on the ABC show "The Bachelor: An Officer and a Gentleman." He is working with Nutrisystem to raise awareness about the need for healthier family lifestyles focusing on everything from food choices to exercise routines.
While serving as a doctor, Baldwin also remains active in his athletic and charitable pursuits, including domestic and global humanitarian projects. He is the founder of the Got Your Back Network, a nonprofit organization that raises money to support families of fallen soldiers.
New York passes legislation restricting sale of DXM to adults 18 years and older
ALBANY, N.Y. — New York Gov. Andrew Cuomo on Friday signed legislation to prohibit pharmacies and stores from selling dextromethorphan to any person younger than 18 years unless they have a prescription.
“This legislation will combat the growing trend of DXM abuse by preventing young people from easily purchasing products that contain DXM,” Cuomo stated. “The overuse of this drug can lead to terrible consequences, so by limiting access to this substance, this new law will prevent tragedies and protect the health of our children.”
“CHPA applauds the New York legislature and Gov. Cuomo for taking a proactive step toward preventing OTC cough medicine abuse,” said Scott Melville, president and CEO of the Consumer Healthcare Products Association. “Teen cough medicine abuse must be addressed in many ways, and restricting access is one part of a multipronged approach that includes talking to teens about the risks and safeguarding medicines in the home," he said. "CHPA launched the Stop Medicine Abuse campaign to give parents and communities the information and resources they need to fight this problem, and we are hopeful that the passage of this law will increase awareness of this abuse and will ignite support for passage of a federal age-18 sales restriction of DXM.”
New York is now the second state to pass an age-18 sales restriction; California previously enacted this law in January 2012.
Under the new law (S.696-B / A.933-B), all retail establishments selling DXM will be required to request proof of age unless the customer appears to be older than 25 years of age. Any retailer violating the new prohibition will be subject to a fine of $250 for each violation.
A number of counties in the state including Nassau and Suffolk have already enacted a restriction on the retail sale of DXM to individuals younger than 18 years.
CHPA also supports the federal bill Preventing Abuse of Cough Treatments (PACT) Act (S. 644) introduced in March by Sens. Bob Casey, D-Pa., and Lisa Murkowski, R-Ark.
ScriptPro integrates products with meth-precursor-tracking system
MISSION, Kan. — ScriptPro’s Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.
ScriptPro said its system now interfaces with the Appriss National Precursor Log Exchange system, currently used by pharmacies and law enforcement agencies in 22 states to track products like pseudoephedrine-based cold and allergy remedies. ScriptPro said the interface eliminates the need to keep a manual log to document sales of the products.
NPLEx works by tracking product requirements, alerting for entry of required patient identification data, sending back approval or denial and blocking any transaction that would cause the customer to exceed legal limits. The National Association of Drug Diversion Investigators makes NPLEx available for free to states that require monitoring of precursor purchases and agree to use the system.
"ScriptPro is pleased to partner with Appriss to offer this time-saving, and in some cases life-saving tool to pharmacies operating in states that have adopted NPLEx," ScriptPro president and CEO Mike Coughlin said. "It reduces manual record keeping and saves operating costs for these pharmacies while at the same time providing better protection for the public."